loading

Eyepoint Pharmaceuticals Inc Azioni (EYPT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
16.71%
11.68
14.03 15.20 9.105 7.683
Cost Of Revenue
0.759
- - - -
Gross Profit
10.93
- - - -
Operating Expenses
45.63%
44.25
30.38 29.60 31.87 29.24
Interest Income/Expense
-
- - 0.435 0.812
Benefits Costs and Expenses
46.08%
40.97
28.04 - - 28.85
Costs And Expenses
60.48%
45.01
28.04 29.60 31.87 28.85
Operating Income/Loss
103.75%
-33.32
-16.35 -14.40 -22.76 -21.55
Nonoperating Income/Loss
72.67%
4.037
2.338 1.786 -0.159 0.39
Income/Loss From Continuing Operations Before Tax
108.93%
-29.28
-14.02 15.20 9.105 -21.16
Income/Loss From Continuing Operations After Tax
107.70%
-29.28
-14.10 -12.61 -22.92 -21.16
Net Income/Loss
107.70%
-29.28
-14.10 -12.61 -22.92 -21.16
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
95.19%
0.0529
1.10 38.34 37.58 37.49
Diluted Average Shares
95.19%
0.0529
1.10 38.34 37.58 37.49
Basic Earnings Per Share
71.87%
-0.55
-0.32 -0.33 -0.61 -0.56
Diluted Earnings Per Share
71.87%
-0.55
-0.32 -0.33 -0.61 -0.56
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):